查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
促紅細胞生成素藥品市場:按類型、按產品、按應用、按國家、按地區 - 行業分析、市場規模、市場份額、預測 2023-2030
市場調查報告書
商品編碼
1299748

促紅細胞生成素藥品市場:按類型、按產品、按應用、按國家、按地區 - 行業分析、市場規模、市場份額、預測 2023-2030

Erythropoietin Drugs Market with COVID-19 Impact Analysis, By Type, By Product, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 358 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年促紅細胞生成素製劑市場規模將達到 70.81 億美元，2023 年至 2030 年復合年增長率為 10.5%

促紅細胞生成素市場 - 市場動態:

終末期腎病治療、抗逆轉錄病毒治療和化療引起的貧血症患病率不斷增加，預計是增加促紅細胞生成素市場需求的主要因素。 此外，除了治療貧血之外，重組人促紅細胞生成素還具有多種治療優勢，例如在腦部疾病方面。 此外，全身施用促紅細胞生成素可以通過跨越血腦屏障來改善神經可塑性並增強許多腦部疾病的認知功能。 然而，促紅細胞生成素製劑的成本上升是預測期內限制市場增長的主要因素之一。

此外，人們對促紅細胞生成素製劑益處的認識提高、易於獲得的報銷以及促紅細胞生成素生物仿製藥的商業化趨勢不斷上升，預計將推動 EPO 治療市場的增長。 COVID-19 大流行對促紅細胞生成素市場產生了積極影響。 對藥品的需求增加了，對各種醫療服務的需求也增加了。 此外，據說該藥物有助於治療貧血，並且對 COVID-19 有效。

促紅細胞生成素藥物市場 - 細分分析:

全球促紅細胞生成素市場按類型、產品、應用和地區細分。

生物製藥和生物仿製藥分為兩類。 生物仿製藥領域可能會主導市場。 其原因包括強大的產品線、製造商和醫院之間合作關係的加強以及研發資金的增加。

市場按產品分為兩類:促紅細胞生成素和達貝泊汀-ALPHA。 達貝泊汀-ALPHA製劑預計將主導市場。 部分原因是達貝泊汀-ALPHA有助於治療接受癌症化療的患者發生的貧血。

根據應用，市場分為三類:腫瘤學、腎臟疾病、神經病學和其他。 據估計，在預測期內，癌症細分市場將佔據最大的市場份額。 由於酒精、西方生活方式、吸煙和不良飲食習慣，癌症患者不斷增加。 因此，它將推動腫瘤學領域的增長。

促紅細胞生成素市場 - 競爭格局:

對促紅細胞生成素製劑的需求不斷增長推動了全球市場的增長。 此外，市場參與者還關注新產品發布、合作夥伴關係、合資企業、聯盟和區域增長。 此外，癌症患者貧血的增加正在推動促紅細胞生成素市場的增長。 此外，市場參與者用於加強和擴展業務的策略包括研發支出、併購和市場開發。 例如，2022 年 3 月，Zydus Lifesciences 獲得了治療 Oxemia（Desidustat）的新藥批准。 它還獲得印度藥品監管局 (DCGI) 批准，作為第一種治療慢性腎病 (CKD) 相關貧血的口服藥物。

研究的主要特點

本研究報告提供了促紅細胞生成素市場的市場規模、複合年增長率、估計和預測（2023-2030），並以 2022 年為基準年。

本研究報告闡明了不同細分市場/國家的潛在增長機會，並概述了促紅細胞生成素市場有吸引力的投資主張矩陣。

總體報告確定了新的投資機會、現有企業面臨的挑戰以及促紅細胞生成素市場可持續發展的增長動力。

研究範圍詳細討論了 COVID-19 對促紅細胞生成素市場規模、預測、複合年增長率和市場動態的影響。 它還涵蓋了對新冠疫情後促紅細胞生成素市場的詳細見解。

為了向本報告的用戶提供促紅細胞生成素市場的全面了解，我們還對促紅細胞生成素市場進行了競爭格局和關鍵創新者分析。

該研究涵蓋了基於市場規模、增長率和吸引力對所有行業領域進行基準測試的增長前景映射分析。

該報告提供了主要市場參與者的詳細公司概況，以幫助您了解在促紅細胞生成素市場運營的公司的財務信息和戰略舉措。

此外，報告還揭示了全球和區域市場主要參與者的重大收購和合併、合作和合資企業、初創企業、研發和區域擴張。

全球促紅細胞生成素製劑市場報告主要面向該行業的各個利益相關者，包括供應商、投資者、新進入者、分銷商和財務分析師。

內容

第一章促紅細胞生成素市場概述

  • 調查範圍

第 2 章執行摘要

  • 市場細分
  • 競爭考慮因素

第三章促紅細胞生成素製劑主要市場趨勢

  • 促紅細胞生成素製劑市場驅動因素
  • 促紅細胞生成素藥物市場製約因素
  • 促紅細胞生成素製劑的市場機會
  • 促紅細胞生成素藥物市場的未來趨勢

第四章促紅細胞生成素醫藥行業調查

  • PEST分析
  • 波特五力分析
  • 增長前景圖
  • 監管框架分析

第五章促紅細胞生成素市場:COVID-19 的影響分析

  • 新冠肺炎 (COVID-19) 疫情之前的影響分析
  • 新冠肺炎 (COVID-19) 疫情後影響分析

第六章促紅細胞生成素市場狀況

  • 2022 年促紅細胞生成素製劑市場份額分析
  • 主要製造商的詳細數據
    • 現有公司分析
    • 初創企業分析

第 7 章促紅細胞生成素市場 - 按類型

  • 概述
    • 按類型劃分的細分市場份額分析
    • 生物製劑
    • 生物仿製藥

第 8 章促紅細胞生成素市場 - 按產品

  • 概述
    • 按產品劃分的細分市場份額分析
    • 促紅細胞生成素
    • 達貝泊汀阿爾法

第 9 章促紅細胞生成素市場 - 按應用

  • 概述
    • 按應用劃分的細分市場份額分析
    • 癌症
    • 腎臟疾病
    • 神經病學
    • 其他

第 10 章促紅細胞生成素市場 - 按地區

  • 簡介
  • 北美
    • 概述
    • 北美促紅細胞生成素製劑主要生產商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲促紅細胞生成素製劑的主要製造商
    • 德國
    • 意大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 其他
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區主要促紅細胞生成素製劑生產商
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳大利亞
    • 泰國
    • 印度尼西亞
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲促紅細胞生成素製劑的主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲
    • 概述
    • 中東和非洲促紅細胞生成素製劑的主要製造商
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第十一章主要供應商分析-促紅細胞生成素製藥行業

  • 競賽儀表板
  • 公司簡介
    • AstraZeneca（UK）
    • Lupin（India）
    • Bristol-Myers Squibb Company（US）
    • Endo International plc（Ireland）
    • JCR Pharmaceuticals Co., Ltd（Japan）
    • Pfizer Inc（US）
    • Teva Pharmaceutical Industries Ltd（Israel）
    • Sun Pharmaceutical Industries Ltd（India）
    • Dr. Reddy's Laboratories Ltd（India）
    • Mylan NV（US）
    • Novartis AG（Switzerland）
    • Cipla Inc（India）
    • Shanghai Dahua Pharmaceutical Co., Ltd（China）

第十二章分析師的全面觀點

Product Code: ANV1338

REPORT HIGHLIGHT

Erythropoietin drugs market size was valued at USD 7,008.1 Million in 2022, expanding at a CAGR of 10.5% from 2023 to 2030.

Erythropoietin (EPO) is also known as hematopoietin, a glycoprotein hormone secreted from the kidneys that play an important role in the development of red blood cells (RBCs) in the bone by stimulating the bone marrow tissues. Additionally, a rise in RBC count increases the hemoglobin level in the bloodstream and delivers a sufficient amount of oxygen to every part of the body. Moreover, erythropoietin medications are largely used in the treatment of anemia caused by end-stage renal disease (ESRD) and dialysis procedures.

Erythropoietin Drugs Market- Market Dynamics:

The increasing prevalence of anemic conditions caused by ESRD treatment, antiretroviral treatment, and chemotherapy are major factors projected to increase the demand for the erythropoietin market. Additionally, besides treating anemia, several therapeutic advantages are associated with recombinant human erythropoietin such as brain disorders. Moreover, if erythropoietin is administered systematically, it passes the blood-brain barrier as a result improving neuroplasticity and rising cognitive functions in many brain disorders. However, the increasing cost of erythropoietin drugs is one of the major factors that could restrain the market growth during the forecast period.

Furthermore, increasing awareness regarding the advantages of erythropoietin therapeutics drugs, readily available reimbursements, and rising trends of commercialization for erythropoietin biosimilars are expected to boost the EPO drugs market growth. The COVID-19 pandemic had a positive impact on the erythropoietin drugs market. It increased the demand for medicines and also increased the demand for various medical services. Additionally, the drug is helpful in anemia treatment and works against COVID-19.

Erythropoietin Drugs Market- Segmentation Analysis:

The global erythropoietin drugs market is segmented on the basis of type, product, application, and region.

The market is divided into two categories based on type: biologics and biosimilars. The biosimilars sector is likely to dominate the market. Due to the strong product pipeline, an increasing partnership among manufacturers & hospitals, and rising funds for development & research.

The market is divided into two categories based on product: erythropoietin and darbepoetin-alfa. The darbepoetin-alfa sector is expected to possess the market. This is partially due to darbepoetin-alfa helping in treating anemia that occurs in a patient who received chemotherapy for cancer.

The market is divided into three categories based on application: cancer, renal diseases, neurology, and others. The cancer sector is estimated to hold the largest market share during the forecast period. Cancer cases are increasing due to the adoption of alcohol, western lifestyle, smoking, and poor diet choice. Thus in turn propel the cancer segment growth.

Erythropoietin Drugs Market-Competitive Landscape:

The increasing demand for erythropoietin drugs thus increases the market growth globally. Additionally, market players are focusing on new product launches, partnerships, joint ventures, collaborations, and regional growth. Moreover, an increase in anemia in cancer patients boosted the erythropoietin drug market growth. Furthermore, strategies used by market players to strengthen and expand their business include R&D spending, mergers & acquisitions, and distribution channel development. For instance, in March 2022, Zydus Lifesciences a company received the new drug approval for Oxemia (Desidustat). Additionally, it is a first-of-its-kind oral treatment for anemia associated with chronic kidney disease(CKD), from the Drugs Controller General of India (DCGI).

Key features of the study:

This proposed research study on erythropoietin drugs market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for erythropoietin drugs market.

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the erythropoietin drugs market.

Impact of COVID-19 on erythropoietin drugs market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on erythropoietin drugs market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the erythropoietin drugs market, we have also included competitive landscape and key innovator analysis for the Erythropoietin Drugs Market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offersdetailed company profiling featuring major market participantswhich will help users to understand their financial information and strategic initiatives of players operating in the erythropoietin drugs market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The global erythropoietin drugs market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ERYTHROPOIETIN DRUGS MARKET KEY PLAYERS

  • AstraZeneca (U.K.)
  • Lupin (India)
  • Bristol-Myers Squibb Company (U.S.)
  • Endo International plc (Ireland)
  • JCR Pharmaceuticals Co., Ltd (Japan)
  • Pfizer Inc (U.S.)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Sun Pharmaceutical Industries Ltd (India)
  • Dr. Reddy's Laboratories Ltd (India)
  • Mylan N.V. (U.S.)
  • Novartis AG (Switzerland)
  • Cipla Inc (India)
  • Shanghai Dahua Pharmaceutical Co., Ltd (China)

GLOBALERYTHROPOIETIN DRUGS MARKET, BY TYPE

  • Biologics
  • Biosimilars

GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY PRODUCT

  • Erythropoietin
  • Darbepoetin-alfa

GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY APPLICATION

  • Cancer
  • Renal Diseases
  • Neurology
  • Others

GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Erythropoietin Drugs Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Erythropoietin Drugs Market Snippet by Type
    • 2.1.2. Erythropoietin Drugs Market Snippet by Product
    • 2.1.3. Erythropoietin Drugs Market Snippet by Application
    • 2.1.4. Erythropoietin Drugs Market Snippet by Country
    • 2.1.5. Erythropoietin Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Erythropoietin Drugs Key Market Trends

  • 3.1. Erythropoietin Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Erythropoietin Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Erythropoietin Drugs Market Opportunities
  • 3.4. Erythropoietin Drugs Market Future Trends

4. Erythropoietin Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Erythropoietin Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Erythropoietin Drugs Market Landscape

  • 6.1. Erythropoietin Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Erythropoietin Drugs Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022&2030 (%)
    • 7.1.2. Biologics
    • 7.1.3. Biosimilars

8. Erythropoietin Drugs Market - By Product

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2022&2030 (%)
    • 8.1.2. Erythropoietin
    • 8.1.3. Darbepoetin-alfa

9. Erythropoietin Drugs Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 9.1.2. Cancer
    • 9.1.3. Renal Diseases
    • 9.1.4. Neurology
    • 9.1.5. Others

10. Erythropoietin Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Erythropoietin Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Erythropoietin Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Erythropoietin Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Erythropoietin Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Erythropoietin Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Erythropoietin Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. AstraZeneca (U.K.)
    • 11.2.2. Lupin (India)
    • 11.2.3. Bristol-Myers Squibb Company (U.S.)
    • 11.2.4. Endo International plc (Ireland)
    • 11.2.5. JCR Pharmaceuticals Co., Ltd (Japan)
    • 11.2.6. Pfizer Inc (U.S.)
    • 11.2.7. Teva Pharmaceutical Industries Ltd (Israel)
    • 11.2.8. Sun Pharmaceutical Industries Ltd (India)
    • 11.2.9. Dr. Reddy's Laboratories Ltd (India)
    • 11.2.10. Mylan N.V. (U.S.)
    • 11.2.11. Novartis AG (Switzerland)
    • 11.2.12. Cipla Inc (India)
    • 11.2.13. Shanghai Dahua Pharmaceutical Co., Ltd (China)

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Erythropoietin Drugs Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Erythropoietin Drugs Market, by Type2018-2030 (USD Million)
  • TABLE Erythropoietin Drugs Market: ProductSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Erythropoietin Drugs Market, by Product2018-2030 (USD Million)
  • TABLE Erythropoietin Drugs Market: Regional snapshot (2022)
  • TABLE Erythropoietin Drugs Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Erythropoietin Drugs Market, by Application 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Erythropoietin Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Erythropoietin Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Erythropoietin Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Erythropoietin Drugs Market, by Product, 2018-2030 (USD Million)
  • TABLE North America Erythropoietin Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Erythropoietin Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Erythropoietin Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE EuropeErythropoietin Drugs Market, by Product, 2018-2030 (USD Million)
  • TABLE Europe Erythropoietin Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Erythropoietin Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Erythropoietin Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Erythropoietin Drugs Market, by Product, 2018-2030 (USD Million)
  • TABLE Asia Pacific Erythropoietin Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Erythropoietin Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Erythropoietin Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Erythropoietin Drugs Market, by Product, 2018-2030 (USD Million)
  • TABLE Latin America Erythropoietin Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Erythropoietin Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Erythropoietin Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Erythropoietin Drugs Market, by Product, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Erythropoietin Drugs Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Erythropoietin Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022&2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Product segment market share analysis, 2022&2030
  • FIGURE Product segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022&2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Erythropoietin Drugs Market share and leading players, 2022
  • FIGURE Europe Erythropoietin Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific Erythropoietin Drugs Market share and leading players, 2022
  • FIGURE Latin America Erythropoietin Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa Erythropoietin Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Erythropoietin Drugs Market share analysis by country, 2022
  • FIGURE Germany Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE NetherlandsErythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE SwedenErythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE PolandErythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Erythropoietin Drugs Market share analysis by country, 2022
  • FIGURE India Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Erythropoietin Drugs Market share analysis by country, 2022
  • FIGURE Brazil Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE ColombiaErythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Erythropoietin Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)